Flowvium
Volver al Explorador

CVS Health Corporation

CVSintermediary

CVS Health is one of the largest healthcare companies in the US, operating an integrated model spanning pharmacy benefits management (Caremark), health insurance (Aetna), retail pharmacy (9,900 stores), and primary care clinics (Oak Street Health, MinuteClinic).

Compartir:
Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($357B)

Datos estáticos (cargando finanzas en tiempo real…)

Health Services (Caremark PBM) (38%)
Health Insurance (Aetna) (35%)
Pharmacy & Consumer Wellness (22%)
Corporate / Other (5%)

Composición de segmentos y clientes principales

Detalles del producto

Pharmacy Benefits (CVS Caremark)38%

One of the three largest pharmacy benefit managers (PBMs) in the US. Manages drug coverage for 100M+ plan members.

Health Insurance (Aetna)35%

Aetna commercial, Medicare Advantage, and Medicaid health plans serving 24M+ members acquired for $69B in 2018.

Retail Pharmacy (CVS Pharmacy)22%

9,900+ retail pharmacy locations. Filling 1.5B+ prescriptions annually. Also includes front-store retail.

Health Services (MinuteClinic / Oak Street)5%

Primary care clinics (1,100+ MinuteClinics, 200+ Oak Street Health centers). Vertical integration into care delivery.

Contexto macro y de mercado

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

CMS 메디케어 최종 수가 발표 (2026.Q2)UNH/HUM/CVS Q1 실적 (2026.04)IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de CVS Health Corporation impulsado por IA.

Información de la Empresa

Sede Central

Woonsocket, Rhode Island, USA

Fundación

1963

Empleados

300,000+

Sitio Web

cvshealth.com

Estado del sector헬스케어

Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Temas clave

  • CMS 메디케어 어드밴티지 수가 인하 → 보험사 마진 압박
  • AI 영상진단·병리학 도입 가속 — Tempus, Veracyte 수혜
  • GLP-1 보험 적용 확대 논의 → UNH·CVS 비용 증가 리스크

Próximos catalizadores

  • CMS 메디케어 최종 수가 발표 (2026.Q2)
  • UNH/HUM/CVS Q1 실적 (2026.04)